Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT07279844

An Open-label, Observational, Long-term Follow-up Study Evaluating the Safety and Efficacy of RGL-193 Putamen Injection in Patients With Primary Parkinson's Disease

Status
Not Yet Recruiting
Phase
Study type
Observational
Enrollment
6 (estimated)
Sponsor
Anhui Provincial Hospital · Other Government
Sex
All
Age
45 Years – 70 Years
Healthy volunteers
Not accepted

Summary

To evaluate the long-term safety of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Detailed description

An open-label, observational, long-term follow-up study evaluating the safety and efficacy of RGL-193 capsid injection in patients with primary Parkinson's disease over 5 years

Conditions

Interventions

TypeNameDescription
OTHERObservationalLong-term observational

Timeline

Start date
2025-12-15
Primary completion
2029-12-14
Completion
2029-12-14
First posted
2025-12-12
Last updated
2025-12-12

Source: ClinicalTrials.gov record NCT07279844. Inclusion in this directory is not an endorsement.